- 1、本文档共26页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
India-WHOEssentialDrugsProgrammeimplementedbyDelhi
India-WHO Essential Drugs Programme
implemented by
Delhi Society for Promotion of Rational Use of Drugs (since 1997)
Delhi State
Population – 14 million
Total no. of hospital beds – 4000
Teaching hospitals – 2
Total number of health centers – 158
Drug annual budget – Rs. 400 million
($ 8 million)
Before Drug Policy - 1994
Access
30-35% of health budget spent on drugs yet scarcity of drugs in the hospitals and both patients and doctors were not satisfied
Access
Shortage of drugs in the public health facilities
Multiple procurement arrangements leading to sub-optimal utilization of resources
Uncertainty of quality of drugs
Before Drug Policy - 1994
Before Drug Policy - 1994
Quality assurance
Erratic and unreliable distribution system –
Drugs nearing expiry drugs
Drugs not needed (combination drugs)
Herbal drugs
Money wasted on substandard drugs
After Drug Policy-1997
Principles of procurement
Procurement restricted to essential drug list
90% of drugs budget spent on essential drugs
After Drug Policy-1997
Pooling of drug requirement of all state health facilities
System of inviting quotations by each institution independently abandoned
After Drug Policy-1997
Level playing field to all bidders
No special preferences to public sector undertakings and small scale units
Pooled procurement system set up with a standing Special Purchase Committee to secure transparency and objectivity
Standing Purchase Committee
Chairperson is a non-government person
Principal Secretary Health
State Director Health Services
State Drugs Controller
Nominee of the State Finance Department
Nominee of the State Law Department
An eminent clinical pharmacologist
Chairperson, Committee for selection of essential drugs
Head of institution
Non officials
An eminent administrator
An eminent clinical pharmacologist
A Finance contract expert
A leading private practitioner
This was an innovative move intended to bring outside expertise, transparency and objectivity
Purchase committee
Close li
您可能关注的文档
- GOVERNMENTOFSOUTHERNSUDAN.ppt
- PovertyEradicationStrategyPaper(PRSP).ppt
- PRPsandPRFs.ppt
- Chapter1–AuditingandAssuranceServices.ppt
- 韩国地区网络医院.PDF
- InterAgencyAgreement(IAA)&InternetPaymentPlatform(.ppt
- BABIPENDAHULUAN.PDF
- NORWEGIANBALANCEOFPAYMENTSSTATISTICS.ppt
- CYP2B6andDrugInteractionsFDAAdvisoryCommitteefor.ppt
- Wearebeginningtolookatourindustrialprocessesas.ppt
文档评论(0)